Fatigue News and Research

RSS

BMY and ZGen present Phase 1B results for PEG-Interferon lambda in HCV patients

Bristol-Myers Squibb Company and ZymoGenetics, Inc. today presented final results from a Phase 1b clinical trial of PEG-Interferon lambda administered with ribavirin in relapsed and treatment-naïve hepatitis C virus (HCV) patients.

2 Nov 2009

Study examines trajectories in sleep disturbances before and after retirement over an extended time window

A study in the Nov.1 issue of the journal Sleep shows that retirement is followed by a sharp decrease in the prevalence of sleep disturbances. Findings suggest that this general improvement in sleep is likely to result from the removal of work-related demands and stress rather than from actual health benefits of retirement.

2 Nov 2009

National Sleep Foundation offers tips and countermeasures to prevent fall-asleep crashes

Sleepiness is often overlooked as a major contributor to vehicle crashes. The National Sleep Foundation's 2009 Sleep in America poll shows that 1% or as many as 1.9 million drivers have had a car crash or a near miss due to drowsiness in the past year. Even more surprising, 54% of drivers (105 million) have driven while drowsy at least once in the past year, and 28% (54 million) do so at least once per month.

2 Nov 2009

New study results of INTUNIV presented at a major psychiatric medical meeting

Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended Release Tablets, at a major psychiatric medical meeting today.

31 Oct 2009

Individualized MicroNutrient Testing for patients

In response to the current trend toward personalized medicine, the Beaumont Weight Control Center, affiliated with Beaumont Hospitals, a major Detroit-area health system, now offers individualized MicroNutrient Testing for patients.

31 Oct 2009

Bayer HealthCare's Phase II study results of imaging agent florbetaben

Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at the 19th World Congress of Neurology (WCN).

30 Oct 2009

Tips for reducing neck and back injuries

With school underway, attention is focused on backpack safety. But carrying heavy bags, briefcases, computers, luggage and even handbags can affect anyone.

30 Oct 2009

Dr. Chao Herbal Drink Line releases two all-natural, vegan beverages

The Dr. Chao Herbal Drink Line released two all-natural, vegan beverages to enhance sexual health and combat premenstrual symptoms. The new Adult and Lady drinks have no sugar, artificial sweeteners or preservatives, glutens, and caffeine, do not require costly prescriptions and have health benefits derived from the recipes of a 19th-century Chinese herbalist.

30 Oct 2009

New study reviews science behind the efficacy of biofield therapies on pain management

Biofield therapies, which claim to use subtle energy to stimulate the body's healing process, are promising complementary interventions for reducing the intensity of pain in a number of conditions, reducing anxiety for hospitalized patients and reducing agitated behaviors in dementia, over and above what standard treatments can achieve.

30 Oct 2009

Human Genome Sciences declares financial results for third quarter 2009; reports increased revenue growth

Human Genome Sciences, Inc. today announced financial results for the quarter ended September 30, 2009, and provided highlights of recent key developments.

30 Oct 2009

New herbal medicinal product for reducing mental and physical stress

Marketed under the trade name Vitango® and now available from pharmacies, the product is a special extract of a highly resilient plant called Golden Root (Rhodiola rosea) that grows in the freezing conditions of Northern Europe and Asia's mountain peaks.

29 Oct 2009

CNS Response to present results from depression efficacy study at U.S. Psychiatric and Mental Health Congress

CNS Response, Inc. announced that the company will present top-line results from its multi-site clinical trial next week at the U.S. Psychiatric and Mental Health Congress. "Referenced-EEG (rEEG®) Efficacy Compared to Star*D for Patients with Depression Treatment Failure: First Look at Final Results," will be presented by Charles DeBattista, M.D. on Monday, November 2nd, at 3:45 to 6:45 p.m. The conference is being held at the Mandalay Bay South Convention Center in Las Vegas, NV.

29 Oct 2009

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

Recent news articles regarding Swine Flu H1N1 have been widespread. The virulence of the strain among humans and its implications for pandemic disease in humans may lead to increased interest in homeopathic treatments for Swine Flu H1N1.

29 Oct 2009

Researchers find healthy dose of exercise good for lymphoma patients receiving chemotherapy

A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.

28 Oct 2009

Arzerra drug approved by FDA for treating chronic lymphocytic leukemia

The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow.

27 Oct 2009

Swine flu 'emergency' declaration could mean expedited care

President Barack Obama declared a state of emergency as the number of swine flu cases soars and vaccine production doesn't keep up with demand.

26 Oct 2009

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.

26 Oct 2009

Hypothalamic dysfunction can cause Chronic Fatigue Syndrome

Dr. Oz's guest Jacob Teitelbaum, MD, best-selling author of From Fatigued to Fantastic! (Avery Penguin Group) and Pain Free 1-2-3 (McGraw-Hill), suffered from CFS when he was in medical school and had to drop out for a year to recover.

24 Oct 2009

Updated data on XL184 study in patients with glioblastoma multiforme presented

Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

24 Oct 2009

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar® (sorafenib) tablets for the treatment of patients with radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer.

23 Oct 2009

Fatigue News and Research

BMY and ZGen present Phase 1B results for PEG-Interferon lambda in HCV patients

Study examines trajectories in sleep disturbances before and after retirement over an extended time window

National Sleep Foundation offers tips and countermeasures to prevent fall-asleep crashes

New study results of INTUNIV presented at a major psychiatric medical meeting

Individualized MicroNutrient Testing for patients

Bayer HealthCare's Phase II study results of imaging agent florbetaben

Tips for reducing neck and back injuries

Dr. Chao Herbal Drink Line releases two all-natural, vegan beverages

New study reviews science behind the efficacy of biofield therapies on pain management

Human Genome Sciences declares financial results for third quarter 2009; reports increased revenue growth

New herbal medicinal product for reducing mental and physical stress

CNS Response to present results from depression efficacy study at U.S. Psychiatric and Mental Health Congress

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

Researchers find healthy dose of exercise good for lymphoma patients receiving chemotherapy

Arzerra drug approved by FDA for treating chronic lymphocytic leukemia

Swine flu 'emergency' declaration could mean expedited care

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Hypothalamic dysfunction can cause Chronic Fatigue Syndrome

Updated data on XL184 study in patients with glioblastoma multiforme presented

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News